Image Credits: Canva
Heart attacks and strokes are among the leading causes of death globally, with millions suffering from cardiovascular diseases (CVD) every year. There are more than seven million people in the UK alone, with about 100,000 patients experiencing heart attacks annually. However, a group of researchers at University College London (UCL) estimate that one 'polypill' taken daily day could eliminate a majority of these cases dramatically lowering death tolls.
The proposed polypill, a combination of a statin and three blood pressure-lowering drugs, has been under study for over two decades. Experts argue that introducing this pill universally for individuals aged 50 and above could be more effective than the current NHS Health Check, which assesses risk factors every five years for those aged between 40 and 74.
Studies have repeatedly proven the effectiveness of the polypill in preventing CVD. A groundbreaking 2019 study in The Lancet found that five years' use of the polypill cut the risk of heart attack and stroke by a third. In addition, previous modelling analyses have estimated that if given universally to people over 55, the polypill might be able to prevent 80% of heart attacks and strokes.
Today, the NHS Health Check follows a risk-based model in which patients are tested for CVD risk factors and treated with drugs accordingly. Yet, as per UCL's study, this system has serious flaws:
Low Uptake: Just 40% of those eligible for the NHS Health Check choose to have it, leaving a considerable number of at-risk patients undiagnosed and untreated.
Ineffective Prediction of Risk: The majority of heart attacks and strokes happen to people at average risk levels, thus making it challenging to identify the need for intervention effectively.
Limited Effectiveness: Even at maximum take-up, the NHS Health Check programme is predicted to have fewer health impacts compared to a polypill initiative applied to the whole population.
One of the big benefits of the polypill is that it is so easy. In contrast to the existing screening-based model, the polypill scheme would not involve complicated medical tests or lengthy risk assessments. Instead, people reaching 50 would just have to fill out a few questions to determine possible side effects before they were prescribed.
Professor Aroon Hingorani of the UCL Institute of Cardiovascular Science, one of the strongest proponents of this scheme, says:
"Finally, the time is now to do much better on prevention. A population approach would prevent a lot more heart attacks and strokes than is done today with a strategy of trying to target a smaller group only."
Aside from the possible health implications, the polypill is also an economic solution. The drugs used are off-patent, thus cheap to produce and distribute. With the vast economic cost of managing CVD-related illnesses, a preventive model could result in substantial cost-saving for the NHS in the future.
The polypill has been proven to be effective by numerous international trials. In 2019, a randomised trial in rural Iran discovered that participants who took the polypill for five years had a 34% reduced risk of having a heart attack or stroke compared to non-participants.
Likewise, modelling research has indicated that even if only 8% of people aged over 50 took up the polypill regimen, it would still be more beneficial to their health than the NHS Health Check programme.
One of the main objections to the polypill strategy is the suggestion that it might result in the unnecessary medicalisation of a significant proportion of the population. But, it is argued, it should be considered as a preventative measure, not as mass medication.
Professor Sir Nicholas Wald of UCL's Institute of Health Informatics explains:
"Instead of being a 'medicalisation' of a significant proportion of the population, a polypill programme is a prevention measure to prevent an individual from becoming a patient."
He compares it with public health measures like water fluoridation or compulsory seatbelts—interventions that have been shown to have a significant impact in reducing public health danger at low individual cost.
With the evidence in favour of the polypill's effectiveness and viability overwhelming, experts are calling on the NHS to act now. It is their belief that substituting the NHS Health Check with a polypill-based prevention program could be the UK government's flagship policy under its pledge to put disease prevention ahead of cure.
As Professor Hingorani points out, "The status quo is not a justifiable option." With CVD still a major cause of death globally, taking a population-wide polypill approach could be a turning point for preventative medicine, potentially saving thousands of lives annually. The question now is whether the NHS will take up this call and establish a policy with the potential to transform the prevention of cardiovascular disease on a national level.
Credit: X
Two people have suffered burn injuries in Mumbai after a cluster of gas-filled balloons exploded and turned into a ball of fire inside a residential building’s lift earlier this week.
The incident occured at Anmol Towers, a residential building opposite a petrol pump in Mumbai's Goregaon West and police have registered a case against the balloon vendor, according to NDTV.
CCTV footage shows a woman entering the lift with a small trolley, followed by a man carrying several balloons packed in a large bag. Moments later, the balloons mysteriously caught fire, leading to the blast inside the elevator.
Despite flames briefly covering the CCTV camera, the woman and two men were seen running out of the elevator seconds later. In the end, the clip shows the elevator doors shutting as flames erupt at the centre of the lift.
It was unclear what type of gas was used to inflate the balloons. However, while many consumers assume decorative balloons are filled with helium, a non-combustible gas, authorities and safety experts suggest that it is highly possible that hydrogen was used instead.
Mumbai police have urged the public to exercise caution and warned balloon sellers against using flammable gases, particularly in residential buildings and enclosed areas.
Hydrogen has a very wide range of flammability in air (4-75 percent by volume) and requires very low energy to ignite. It often causes explosions rather than just fires, especially in confined spaces.
In high concentrations in enclosed areas, hydrogen acts as a simple asphyxiant by displacing oxygen, which can lead to dizziness, unconsciousness, or death. Additionally, hydrogen fires burn with a nearly invisible, pale blue flame, making them almost impossible to detect with the naked eye during daylight.
Moreover, hydrogen gas also burns faster than most conventional fuels, increasing the risk of deflagration (subsonic) or detonation (supersonic).
On the other hand, as a noble gas, helium has a completely filled outer shell of electrons, meaning it does not react with other elements or catch fire in the presence of oxygen and heat.
Along with this, unlike hydrogen, which is also lighter than air but highly explosive, helium will not ignite even if exposed directly to a flame or spark and it can can act as a buffer and actually suppress flames by displacing oxygen in the immediate area.
For minor burns, immediately run cool (not cold) water over the area for 10–20 minutes, remove jewelery or tight clothing near the injured area and cover with a sterile bandage. A minor burn might need emergency care if it affects the eyes, mouth, hands or genitals.
However, for serious and large burns, protect the burned person from further harm and ensure that they are breathing. Loosely cover the area with gauze or a clean cloth and raise the burned area above heart level, if possible.
As you call emergency services, watch for symptoms of shock which include cool, clammy skin, weak pulse and shallow breathing.
Seek immediate care for burns, which:
Globally, about 10 million people experience burns and about 180,000 die from them each year.
A woman with no travel history has died from Nipah virus in Bangladesh, the World Health Organization has confirmed.
The patient, aged between 40 and 50, developed a fever and headache-like symptoms consistent with the virus, followed by hypersalivation, disorientation and convulsion on 21 January.
The case was reported in the northern Naogaon district, Sharmin Sultana, senior scientific officer at the Institute of Epidemiology, Disease Control and Research, later said.
She died on January 28 and was confirmed to be infected with the virus the day after. Although she had no travel history, she regularly consumed raw date palm sap, reports suggest.
The WHO said all 35 people who had contact with the now-deceased patient were being monitored and have tested negative for the virus. No new cases had been detected to date.
Since its emergence in 2001, Bangldesh has reported cases of Nipah virus in humans every year. In 2025, four laboratory-confirmed fatal cases were reported in the country.
The Nipah virus outbreak began in West Bengal, India in January with two hospital nurses at AIIMS, Kolkata, testing positive for the infection and being quarantined, prompting widespread testing. Soon after, five cases, including a doctor and a staff member, were confirmed and over 100 people were quarantined.
However, one of the nurses, a 25-year-old unidentified man has now made a recovery and revealed his experience with the virus, claiming that despite irritation in the throat and uncertainty about what lay ahead, he had faith in his doctors and fellow nurses.
In an interview with the Metro, he said: “After I was taken off ventilation and regained consciousness, I came to know that I have Nipah. I still had the tube in my mouth, and there was irritation. Despite the irritation and my fear, I had faith in the doctors and nurses.
“I have suffered and I know the symptoms. I will tell people when they should get checked for the Nipah virus. I want to raise awareness about the virus and its symptoms.
“I am not sure how I came in contact with the deadly virus. Maybe it was while treating a patient. But I will continue to work as a nurse. I am waiting to rejoin the hospital,” he added.
The unidentified healthcare professional remains very weak physically and is undergoing physiotherapy to regain his strength. “I was bedridden for over a month. I am still very weak and have an unstable gait. So, I am undergoing physiotherapy,” he said.
The other nurse, a woman, remains in a coma but has been taken off ventilation support, a hospital official confirmed this week.
According to WHO, Nipah virus is a zoonotic illness which means it is mostly transmitted from animals to humans through bats. However, it can also spread through fruits that have been contaminated by the saliva, urine or droppings of infected bats. Human-to-human transmission can also occur through close contact with an infected person or their bodily fluids.
The illness has a 75 percent fatality rate, and there are no vaccines to protect the public.
The virus was first identified in 1998 during an outbreak among pig farmers in Malaysia and soon made its way to India and Bangladesh in 2001, with cases often involving family members or caregivers tending to the infected patient.
READ MORE: Nipah vs Bird Flu in India: Which Virus Poses A Greater Threat To Humans?
Although the Nipah virus has caused only a few known outbreaks in Asia, it infects a wide range of animals and causes severe disease and death in people. Some of its common symptoms include:
Samples collected from the patient’s home and workplaces, including pets and partially eaten fruits dropped by bats, all tested negative for the virus, and the exact source of the infection could not be identified.
Credits: Canva
Wet Wipes Waring: 59 people have fallen ill, with one dead, after using non-alcoholic, non-sterile, infected wet wipes in UK. The UK Health Security Agency (UKHSA) and Medicines and Healthcare products Regulatory Agency (MHRA) issued a warning, and said that there is still "an ongoing risk of infection associated with their use". The bacteria that is causing this infection is burkholderia stabilis or B. stabilis.

The UKHSA also in its warning included names of four different wet wipes and asked people to avoid using them.
The Pharmaceutical Journal noted that the UKHSA and MHRA published a joint statement that warned people that they should not use non-sterile, non-alcoholic wipes in their homes and first-aid kits.
After an outbreak investigation conducted by MHRA in 2025, four products were identified to be contaminated with Burkholderia stabilis. “There have been 59 confirmed cases of Burkholderia stabilis associated with some non-sterile alcohol-free wipe products — identified in an outbreak in the United Kingdom from January 2018 to 3 February 2026,” the statement said.
“A small number of cases continue to be detected. These have included some serious infections which have required hospital treatment and one death has been attributed to Burkholderia stabilis infection.”
UKHSA and MHRA is telling people to look out for wipes marked 'sterile' to be used on wounds or broken skin.
UKHSA on its official website notes: 'Burkholderia are a type of bacteria found naturally in the environment, including in soil and water. Burkholderia stabilis is one species within this group. While many people never encounter problems with this type of bacteria, it can cause serious infections in certain circumstances, particularly among vulnerable individuals.'
Read: Does Bigger Penis Help You Ski Better? Why Olympians Are Injecting Hyaluronic Acid - Explained
The UKHSA notes: "The risk of acquiring infection is generally very low. Infections can occur through contact with contaminated products on broken or damaged skin, or through introduction of bacteria through medical devices such as intravenous lines."
© 2024 Bennett, Coleman & Company Limited